Status:
COMPLETED
Connect Lung Outcomes With Bronchodilator Use
Lead Sponsor:
Pulmonary Critical Care Associates of Baltimore
Conditions:
Chronic Obstructive Pulmonary Disease
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
To determine the accuracy of the Respimetrix flow-volume monitoring device in measuring the patient's inspiratory capacity as compared to gold-standard measurements of inspiratory capacity on pulmonar...
Detailed Description
1. Specific Aim #1: Compare the performance of the flow-volume test device to standard pulmonary function measurements. The investigators hypothesize that measurements of inspiratory capacity with...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older who are being seen in the pulmonary clinic including Asthma and Chronic Obstructive Pulmonary Disease (COPD) patients.
- Patients must be willing and able to provide informed consent to participate in the study.
- Patients must be able to use a metered dose inhaler.
Exclusion
- Contraindication to inhaler use
- Tracheostomy
- Incapacitating disability that interferes with the use of the inhaler or execution of the protocol
- Unable to understand informed consent (e.g., non-English speakers)
Key Trial Info
Start Date :
August 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 25 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04417842
Start Date
August 27 2020
End Date
April 25 2022
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pulmonary and Critical Care Associates Of Baltimore
Towson, Maryland, United States, 21286